Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster ... to ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

The Legislature and Gov. Maura Healey last year enacted a pair of new health policy laws, including one aimed at reining in ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help ...

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Elliott Investment Management. Ownership: 12.5%+ Average Cost: n/a. Activist Commentary: Elliott is a very successful and ...